Sasaoka Y, Takagi T, Michiba S, Yamamoto Y, Kumagai Y, Kishimura H
Mar Drugs. 2021; 19(10).
PMID: 34677483
PMC: 8541525.
DOI: 10.3390/md19100584.
Koizumi S, Inoue N, Sugihara F, Igase M
Nutrients. 2019; 12(1).
PMID: 31878021
PMC: 7019356.
DOI: 10.3390/nu12010050.
Mohan S, Kalia K, Mannari J
Indian J Clin Biochem. 2013; 27(4):333-9.
PMID: 24082456
PMC: 3477451.
DOI: 10.1007/s12291-012-0227-6.
Br Med J. 2010; 2(5348):6-7.
PMID: 20789889
PMC: 1872131.
Prockop D
J Clin Invest. 1964; 43:453-60.
PMID: 14135496
PMC: 441938.
DOI: 10.1172/JCI104930.
The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation.
Weiss P, Klein L
J Clin Invest. 1969; 48(1):1-10.
PMID: 5765022
PMC: 322186.
DOI: 10.1172/JCI105957.
Total urinary hydroxyproline excretion in osteomalacia.
Anderson J, Bannister D, Parsons V, Tomlinson R
Calcif Tissue Res. 1967; 1(3):183-91.
PMID: 5633439
DOI: 10.1007/BF02008089.
[The behavior of the "collagen-like protein" in serum of patients with seleroderma before and following treatment with gestagens].
Holzmann H, KORTING G, MORSCHES B, Schlaudecker A
Arch Klin Exp Dermatol. 1967; 230(1):69-83.
PMID: 5613750
Collagen degradation and the response to parathyroid extract in the intact rhesus monkey.
Avioli L, Prockop D
J Clin Invest. 1967; 46(2):217-24.
PMID: 4959908
PMC: 297040.
DOI: 10.1172/JCI105524.
Urinary polypeptides related to collagen synthesis.
Krane S, Munoz A, Harris Jr E
J Clin Invest. 1970; 49(4):716-29.
PMID: 4315304
PMC: 322527.
DOI: 10.1172/JCI106284.
[Serum hyproprotein level as an index for the activity of chronic polyarthritis].
LANGNESS U, KRIEGEL W
Klin Wochenschr. 1969; 47(13):717-20.
PMID: 4192047
DOI: 10.1007/BF01881623.
Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases.
Adibi S, MORSE E, Masilamani S, Amin P
J Clin Invest. 1975; 56(6):1355-63.
PMID: 1202077
PMC: 333112.
DOI: 10.1172/JCI108215.